Mark Neumann
Corporate Officer/Principal chez INTRA-CELLULAR THERAPIES, INC.
Fortune : 2 M $ au 31/03/2024
Profil
Mark Neumann is currently the Chief Commercial Officer & Executive VP at Intra-Cellular Therapies, Inc. Prior to his current position, he served as the Vice President-Global Marketing at Amgen, Inc. from 2016 to 2018.
Before that, he held the position of Vice President-Global Commercialization at Bristol Myers Squibb Co. from 2008 to 2014.
Mr. Neumann completed his undergraduate degree at Lafayette College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/03/2024 | 29 700 ( 0,03% ) | 2 M $ | 31/03/2024 |
Postes actifs de Mark Neumann
| Sociétés | Poste | Début |
|---|---|---|
| INTRA-CELLULAR THERAPIES, INC. | Corporate Officer/Principal | 16/10/2018 |
Anciens postes connus de Mark Neumann
| Sociétés | Poste | Fin |
|---|---|---|
| AMGEN INC. | Sales & Marketing | 01/09/2018 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/05/2014 |
Formation de Mark Neumann
| Lafayette College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| INTRA-CELLULAR THERAPIES, INC. | Health Technology |
